Symptom screening for active tuberculosis in pregnant women living with HIV
References
Additional references
Ahmad Khan F, Verkuijl S, Parrish A, Chikwava F, Ntumy R, El‐Sadr W, et al. Performance of symptom‐based tuberculosis screening among people living with HIV: not as great as hoped. AIDS 2014;28(10):1463‐72.
Bossuyt PM, Irwig L, Craig J, Glasziou P. Comparative accuracy: assessing new tests against existing diagnostic pathways. BMJ 2006;332(7549):1089‐92.
Chu H, Guo H, Zhou Y. Bivariate random effects meta‐analysis of diagnostic studies using generalized linear mixed models. Medical Decision Making 2010;30(4):499‐508.
Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Archives of Internal Medicine 2003;163(9):1009‐21.
Deluca A, Chaisson RE, Martinson NA. Intensified case finding for tuberculosis in prevention of mother‐to‐child transmission programs: a simple and potentially vital addition for maternal and child health. Journal of Acquired Immune Deficiency Syndromes 2009;50(2):196‐9.
Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, Cain KP, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource‐constrained settings: individual participant data meta‐analysis of observational studies. PLoS Medicine 2011;8(1):e1000391.
Getahun H, Sculier D, Sismanidis C, Grzemska M, Raviglione M. Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services. Journal of Infectious Diseases 2012;205(Suppl 2):S216‐27.
Gupta A, Chandrasekhar A, Gupte N, Patil S, Bhosale R, Sambarey P, et al. Symptom screening among HIV‐infected pregnant women is acceptable and has high negative predictive value for active tuberculosis. Clinical Infectious Diseases 2011;53(10):1015‐8.
Hamadeh MA, Glassroth J. Tuberculosis and pregnancy. Chest 1992;101(4):1114‐20.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) – a metadata‐driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics 2009;42(2):377‐81.
Hoffmann CJ, Variava E, Rakgokong M, Masonoke K, van der Watt M, Chaisson RE, et al. High prevalence of pulmonary tuberculosis but low sensitivity of symptom screening among HIV‐infected pregnant women in South Africa. PLoS One 2013;8(4):e62211.
Horsburgh CR, Rubin EJ. Clinical practice. Latent tuberculosis infection in the United States. New England Journal of Medicine 2011;364(15):1441‐8.
Kancheya N, Luhanga D, Harris JB, Morse J, Kapata N, Bweupe M, et al. Integrating active tuberculosis case finding in antenatal services in Zambia. International Journal of Tuberculosis and Lung Disease 2014;18(12):1466‐72.
Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. New England Journal of Medicine 2014;370(23):2211‐8.
LaCourse SM, Cranmer LM, Matemo D, Kinuthia J, Richardson BA, John‐Stewart G, et al. Tuberculosis case finding in HIV‐infected pregnant women in Kenya reveals poor performance of symptom screening and rapid diagnostic tests. Journal of Acquired Immune Deficiency Syndromes 2016;71(2):219‐27.
Lawn SD, Wood R, Wilkinson RJ. Changing concepts of "latent tuberculosis infection" in patients living with HIV infection. Clinical and Developmental Immunology 2011;2011:pii: 980594.
Lawn SD. Point‐of‐care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV‐associated tuberculosis: a state of the art review. BMC Infectious Diseases 2012;12:103.
Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH, et al. Empirical evidence of design‐related bias in studies of diagnostic tests. JAMA 1999;282(11):1061‐6.
Llewelyn M, Cropley I, Wilkinson RJ, Davidson RN. Tuberculosis diagnosed during pregnancy: a prospective study from London. Thorax 2000;55(2):129‐32.
Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y. Chapter 10: Analysing and presenting results. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0.0. The Cochrane Collaboration, 2010. Available from srdta.cochrane.org. The Cochrane Collaboration.
Mathad JS, Gupta A. Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps. Clinical Infectious Diseases 2012;55(11):1532‐49.
Modi S, Cavanaugh JS, Shiraishi RW, Alexander HL, McCarthy KD, Burmen B, et al. Performance of clinical screening algorithms for tuberculosis intensified case finding among people living with HIV in western Kenya. PLoS One 2016;11(12):e0167685.
Modi S (Centers for Disease Control and Prevention). [personal communication]. Conversation with: SM LaCourse (University of Washington) 21 March 2017.
Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of drug‐susceptible tuberculosis. Clinical Infectious Diseases 2016;63(7):e147‐95.
Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, et al. Tuberculosis. Nature Reviews Disease Primers 2016;2:16076.
Rangaka MX, Wilkinson RJ, Glynn JR, Boulle A, van Cutsem G, Goliath R, et al. Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic. Clinical Infectious Diseases 2012;55(12):1698‐706.
Ratnapalan S, Bona N, Chandra K, Koren G. Physicians' perceptions of teratogenic risk associated with radiography and CT during early pregnancy. American Journal of Roentgenology 2004;182(5):1107‐9.
Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology 2005;58(10):982‐90.
Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Saito S, Howard AA, Reid M J, Elul B, Scardigli A, Verkuijl S, et al. TB diagnostic capacity in sub‐Saharan African HIV care settings. Journal of Acquired Immune Deficiency Syndromes 2012;61(2):216‐20.
Salazar‐Austin N, Hoffmann J, Cohn S, Mashabela F, Waja Z, Lala S, et al. Poor obstetric and infant outcomes in HIV‐infected pregnant women with tuberculosis in South Africa: the Tshepiso study. Clinical Infectious Diseases 2017 Sep 26 [Epub ahead of print]. [DOI: 10.1093/cid/cix851]
Shah M, Hanrahan C, Wang ZY, Dendukuri N, Lawn SD, Denkinger CM, et al. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV‐positive adults. Cochrane Database of Systematic Reviews 2016, Issue 5. [DOI: 10.1002/14651858.CD011420.pub2]
Singh N, Perfect JR. Immune reconstitution syndrome and exacerbation of infections after pregnancy. Clinical Infectious Diseases 2007;45(9):1192‐9.
Somoskovi A, Kodmon C, Lantos A, Bartfai Z, Tamasi L, Fuzy J, et al. Comparison of recoveries of mycobacterium tuberculosis using the automated BACTEC MGIT 960 system, the BACTEC 460 TB system, and Lowenstein‐Jensen medium. Journal of Clinical Microbiology 2000;38(6):2395‐7.
StataCorp. Stata Statistical Software. Version Release 14. College Station, TX: StataCorp LP, 2015.
Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database of Systematic Reviews 2014, Issue 1. [DOI: 10.1002/14651858.CD009593.pub3]
Stop TB Partnership. The Paradigm Shift 2016‐2020 Global Plan to End TB. www.stoptb.org/assets/documents/global/plan/GlobalPlanToEndTB_TheParadigmShift_2016‐2020_StopTBPartnership.pdf (accessed 1 February 2017).
Sugarman J, Colvin C, Moran A, Oxlade O. Tuberculosis in pregnancy: an estimate of the global burden of disease. Lancet 2014;2(12):e710–6.
Takwoingi Y, Guo B, Riley RD, Deeks JJ. Performance of methods for meta‐analysis of diagnostic test accuracy with few studies or sparse data. Statistical Methods in Medical Research 2017;26(4):1896‐911. [DOI: 10.1177/0962280215592269]
UNAIDS. Global HIV Statistics Fact Sheet. www.unaids.org/en/resources/fact‐sheet. UNAIDS, (accessed 1 February 2017).
UNITAID. Tuberculosis Diagnostics Technology and Market Landscape 4th edition. unitaid.org/images/marketdynamics/publications/Tuberculosis_diagnostics_technology_and_market_landscape_4th_edition_Oct_2015.pdf (accessed 1 March 2017).
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS‐2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155(8):529‐36.
World Health Organization. Treatment of tuberculosis guidelines. Fourth Edition. apps.who.int/iris/bitstream/10665/44165/1/9789241547833_eng.pdf?ua=1&ua=1. World Health Organization, (accessed 23 March 2017).
World Health Organization. Guidelines for intensified tuberculosis case‐finding and isoniazid preventive therapy for people living with HIV in resource‐constrained settings. whqlibdoc.who.int/publications/2011/9789241500708_eng.pdf. World Health Organization, (accessed 1 February 2017).
World Health Organization. Policy statement: Automated real‐time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system. whqlibdoc.who.int/publications/2011/9789241501545_eng.pdf. World Health Organization, (accessed 1 February 2017).
World Health Organization. Systematic screening for active tuberculosis: principles and recommendations. www.who.int/tb/tbscreening/en/. World Health Organization, (accessed 1 February 2017).
World Health Organization. Guideline on when to start antiretroviral therapy and on pre‐exposure prophylaxis for HIV. apps.who.int/iris/bitstream/10665/186275/1/9789241509565_eng.pdf (accessed 26 April 2017).
World Health Organization. The use of lateral flow urine lipoarabinomannan assay (LF‐LAM) for the diagnosis and screening of diagnosis and screening of active tuberculosis in people living with HIV. Policy update. www.who.int/tb/publications/use‐of‐lf‐lam‐tb‐hiv/en/. World Health Organization, (accessed 21 March 2017).
World Health Organization. Recommendation on 36 months isoniazid preventive therapy to adults and adolescents living with HIV in resource‐constrained and high TB and HIV‐prevalence settings: Update. apps.who.int/iris/bitstream/10665/174052/1/9789241508872_eng.pdf?ua=1&ua=1. World Health Organization, (accessed 24 March 2017).
World Bank. World Bank list of economies. datahelpdesk.worldbank.org/knowledgebase/articles/906519‐world‐bank‐country‐and‐lending‐groups. World Bank, (accessed 4 March 2017).
Zenner D, Kruijshaar ME, Andrews N, Abubakar I. Risk of tuberculosis in pregnancy: a national, primary care‐based cohort and self‐controlled case series study. American Journal of Respiratory and Critical Care Medicine 2012;185(7):779‐84.
Figures and Tables -
Figure 1
Algorithm for TB screening in adults and adolescents living with HIV in HIV‐prevalent and resource‐constrained settings. Reprinted from: Guidelines for intensified tuberculosis case‐finding and isoniazid preventive therapy for people living with HIV in resource‐constrained settings. Copyright: WHO 2011a.
